TSC2 c.558C>G ;(p.F186L)

Variant ID: 16-2105479-C-G

NM_000548.3(TSC2):c.558C>G;(p.F186L)

This variant was identified in 1 publication

View GRCh38 version.



Variant-Specific Resource Links:
gnomAD v2.1.1
Mutalizer Name Checker
Google
UCSC Genome Browser
ClinVar
dbSNP

Publications:

Case Report: Significant Response to Immune Checkpoint Inhibitor Camrelizumab in a Heavily Pretreated Advanced ER+/HER2- Breast Cancer Patient With High Tumor Mutational Burden.

Frontiers In Oncology
Wang, Rong R; Yang, Yuchen Y; Ye, Wei-Wu WW; Xiang, Jianxing J; Chen, Songan S; Zou, Wei-Bin WB; Wang, Xiao-Jia XJ; Chen, Tianhui T; Cao, Wen-Ming WM
Publication Date: 2020

Variant appearance in text: TSC2: 558C>G; Phe186Leu
PubMed Link: 33634015
Variant Present in the following documents:
  • Table_1.xlsx, sheet 8
View BVdb publication page